|
[Related PubMed/MEDLINE]
Total Number of Papers: 402
|
|
|
|
|
[Display Entries]
|
|
|
| |
|
[Entries Per Page]
|
|
per page
|
| |
|
Page Control
|
|
|
|
Page: of
|
|
|
|
| Abbreviation |
: sCD40L |
| Long Form |
: soluble CD40 ligand |
|
| No. |
Year |
Title |
Co-occurring Abbreviation |
| 1 |
2020 |
An animal model of transfusion-related acute lung injury and the role of soluble CD40 ligand. |
BALF, EBD, RBC, TRALI |
| 2 |
2020 |
Biomarkers of platelet activation and cardiovascular risk in the DAPT trial. |
DAPT, MACE, MRP, PCI, PRI |
| 3 |
2020 |
Characteristics of salivary inflammation in obesity. |
BMI |
| 4 |
2020 |
Cytokine profiles in maternal serum are candidates for predicting an optimal timing for the delivery in early-onset fetal growth restriction. |
FGR, sVEGFR-1 |
| 5 |
2020 |
Different roles of soluble CD40 ligand in central nervous system damage. |
CSF, GFAP, MS, NMOSD, TPO |
| 6 |
2020 |
Elevation in Circulating Soluble CD40 Ligand Concentrations in Type 2 Diabetic Retinopathy and Association with its Severity. |
DR, NPDR |
| 7 |
2020 |
Impact of intracoronary nicorandil before stent deployment in patients with acute coronary syndrome undergoing percutaneous coronary intervention. |
ACS, PCI, RCT, SOD |
| 8 |
2020 |
Increased levels of IL-10 and IL-1Ra counterbalance the proinflammatory cytokine pattern in acute pediatric immune thrombocytopenia. |
GRO, ITP, IVIG, PBMCs, RA, TNF-alpha |
| 9 |
2020 |
Lung function and systemic inflammation associated with short-term air pollution exposure in chronic obstructive pulmonary disease patients in Beijing, China. |
CO, COPD, IFN-gamma, IL-4, MCP-1, PM2.5 |
| 10 |
2020 |
Olive polyphenol reduces the collagen-elicited release of phosphorylated HSP27 from human platelets. |
HSP27, HT, OLE |
| 11 |
2020 |
Orthopaedic Surgery Elicits a Systemic Anti-Inflammatory Signature. |
Flt3L, G-CSF, G-MDSCs, GM-CSF, IL-10, IL-1ra, IL-6, PBMCs |
| 12 |
2020 |
Predictive Value of Soluble PD-1, PD-L1, VEGFA, CD40 Ligand and CD44 for Nivolumab Therapy in Advanced Non-Small Cell Lung Cancer: A Case-Control Study. |
anti-PD-1, NSCLC, PFS, sCD44, sPD-1, sPD-L1, VEGF-A |
| 13 |
2020 |
Serum concentration of selected biochemical markers of endothelial dysfunction and inflammation in patients with the varying activity of inflammatory bowel disease. |
IBD |
| 14 |
2020 |
Soluble CD40 Ligand Levels in Children with Newly Diagnosed Graves’ Disease |
CI, GD, hs-CRP, OR, SDS, TRAbs, TSH |
| 15 |
2020 |
The Interplay Between Innate Immunity (TLR-4) and sCD40L in the Context of an Animal Model of Colitis-associated Cancer. |
AOM/DSS, CAC, ELISA, IBD, KO, WT |
| 16 |
2019 |
A Disintegrin and Metalloproteinase 8 as a Potential Blood Biomarker for Early Diagnosis of Gastric Cancer. |
ADAM 8, AGC, EGC, GC, IL-23, IL-8, ROC |
| 17 |
2019 |
Association between the No-Reflow Phenomenon and Soluble CD40 Ligand Level in Patients with Acute ST-Segment Elevation Myocardial Infarction. |
CI, NR, OR, STEMI |
| 18 |
2019 |
Biological variation of immunological blood biomarkers in healthy individuals and quality goals for biomarker tests. |
CVI, IL-1ra, MIP-1beta, sCD14, sgp130, sIL-2Ralpha, sIL-6R, sTNF-RII, TNF-alpha |
| 19 |
2019 |
Cytokine Responses in Severe Traumatic Brain Injury: Where There Is Smoke, Is There Fire? |
IL-1beta, sTBI, TGF-beta, TIMP-1, TNF-alpha |
| 20 |
2019 |
Dyslipidemia induced inflammatory status, platelet activation and endothelial dysfunction in rabbits: Protective role of 10-Dehydrogingerdione. |
CETP, DC, HDL-C, IFN-gamma, LDL-C, NC, PCSK9, sP-selectin |
| 21 |
2019 |
Effect of apixaban compared with warfarin on coagulation markers in atrial fibrillation. |
AF, VKA, vWF |
| 22 |
2019 |
Evaluation of plasma levels of neopterin and soluble CD40 ligand in patients with acute ischemic stroke in upper Egypt: can they surrogate the severity and functional outcome? |
AIS |
| 23 |
2019 |
Evaluation of serum sST2 and sCD40L values in patients with microvascular angina. |
IQR, MVA, sST2 |
| 24 |
2019 |
Impact of the platelet washing process on in vitro platelet properties, and the levels of soluble CD40 ligand and platelet-derived microparticles in the storage media. |
PDMPs, PLT, RANTES |
| 25 |
2019 |
Influence of circadian blood pressure alterations on serum SCUBE-1 and soluble CD40 ligand levels in patients with essential hypertension. |
--- |
| 26 |
2019 |
Lipid levels and selected biomarkers of vascular changes in children with idiopathic headaches - a preliminary report. |
BDNF, HDL, LDL, TC, TG, VEGF |
| 27 |
2019 |
Local Application of Autologous Platelet-Rich Fibrin Patch (PRF-P) Suppresses Regulatory T Cell Recruitment in a Murine Glioma Model. |
GBM, PRF-P |
| 28 |
2019 |
Platelet alpha-granules modulate the inflammatory response under systemic lipopolysaccharide injection in mice. |
GPS, LPS |
| 29 |
2019 |
SHARPIN at the nexus of integrin, immune, and inflammatory signaling in human platelets. |
iPS, LUBAC |
| 30 |
2019 |
The skewed frequency of B-cell subpopulation CD19+ CD24 hi CD38 hi cells in peripheral blood mononuclear cells is correlated with the elevated serum sCD40L in patients with active systemic lupus erythematosus. |
HCs, SLE |
| 31 |
2019 |
[Alpha-momordicin Regulates Hepatocyte Cytokine Expression]. |
alpha-MMC, IL, Th17, TNF-alpha |
| 32 |
2018 |
Changes in inflammatory factors and prognosis of patients complicated with non-alcoholic fatty liver disease undergoing coronary artery bypass grafting. |
CABG, hs-CRP, ICAM-1, MMP-9, NAFLD |
| 33 |
2018 |
Comparison of diverse platelet activation markers as indicators for left atrial thrombus in atrial fibrillation. |
AF, CAD, CBA, LA, LAA, MPAs, sP-selectin, TEE |
| 34 |
2018 |
Differential serum cytokine profile in patients with systemic lupus erythematosus and posterior reversible encephalopathy syndrome. |
ELISA, IL, MRI, PRES, SLE, VEGF |
| 35 |
2018 |
High On-Treatment Platelet Reactivity Determinants on Dual Antiplatelet Therapy in Patients With Ischemic Heart Disease Before Elective Percutaneous Coronary Intervention. |
BMI, CH, DAPT, HOPR, hsCPR, IL-6, LTA 5ADP, sP-selectin |
| 36 |
2018 |
Immature platelets and antiplatelet therapy response to aspirin in Kawasaki disease. |
CAL, IPF, NCAL, sP-selectin |
| 37 |
2018 |
Impact of Tobacco Versus Electronic Cigarette Smoking on Platelet Function. |
E-cigarettes, sP-selectin |
| 38 |
2018 |
Interplay between Oxidative Stress and Platelet Activation in Coronary Thrombus of STEMI Patients. |
oxLDLs, PPCI, SA, sP-selectin, STEMI |
| 39 |
2018 |
New Insight on a Combination of Policosanol and 10-Dehydrogingerdione Phytochemicals as Inhibitors for Platelet Activation Biomarkers and Atherogenicity Risk in Dyslipidemic Rabbits: Role of CETP and PCSK9 Inhibition. |
IFN-gamma, sP-selectin |
| 40 |
2018 |
Platelet-related cytokines among normal body mass index, overweight, and obese Malaysians. |
BMI, MPV, PLT, sP-sel, WC |
| 41 |
2018 |
Putative biomarkers of vedolizumab resistance and underlying inflammatory pathways involved in IBD. |
anti-TNF, IBD, IL |
| 42 |
2018 |
Soluble CD40 ligand disrupts the blood-brain barrier and exacerbates inflammation in experimental autoimmune encephalomyelitis. |
BBB, EAE, HBMEC, MS |
| 43 |
2018 |
[Establishment of An Animal Model of Transfusion-related Acute Lung Injury and the Role of Soluble CD40 Ligand in the Development of Transfusion-related Acute Lung Injury]. |
ELISA, NS, PRBC, TRALI |
| 44 |
2018 |
[High On-Treatment Platelet Reactivity Determinants on Dual Antiplatelet Therapy in Patients With Ischemic Heart Disease Before Elective Percutaneous Coronary Intervention]. |
BMI, CH, DAPT, HOPR, hsCPR, IL-6, LTA 5ADP, sP-selectin |
| 45 |
2018 |
[Proinflammatory state in obese children]. |
hs-CRP, IL-6, MCP-1, TNF-alpha |
| 46 |
2017 |
Association between aqueous humor and vitreous fluid levels of Th17 cell-related cytokines in patients with proliferative diabetic retinopathy. |
PDR |
| 47 |
2017 |
Association of High-Mobility Group Box-1 With Th Cell-Related Cytokines in the Vitreous of Ocular Sarcoidosis Patients. |
ERM, HMGB1, PDR |
| 48 |
2017 |
Carotid Endarterectomy Induces the Release of Inflammatory Markers and the Activation of Coagulation as Measured in the Jugular Bulb. |
CEA, I/R, IL-6, JB, PAI-1, RA |
| 49 |
2017 |
Circulating CD40 and sCD40L Predict Changes in Renal Function in Subjects with Chronic Kidney Disease. |
CKD, eGFR |
| 50 |
2017 |
Correlation between Intravoxel Incoherent Motion Magnetic Resonance Imaging Derived Metrics and Serum Soluble CD40 Ligand Level in an Embolic Canine Stroke Model. |
IVIM |
| 51 |
2017 |
Fibrin-Targeted and H2O2-Responsive Nanoparticles as a Theranostics for Thrombosed Vessels. |
TNF-alpha |
| 52 |
2017 |
Frontline Science: c-Myc regulates P-selectin glycoprotein ligand-1 expression in monocytes during HIV-1 infection. |
KO, PSGL-1 |
| 53 |
2017 |
Human CD40 ligand deficiency dysregulates the macrophage transcriptome causing functional defects that are improved by exogenous IFN-gamma. |
CD40L, rhIFN-gamma |
| 54 |
2017 |
Immunometabolic profiling of patients with multiple sclerosis identifies new biomarkers to predict disease activity during treatment with interferon beta-1a. |
IFN, IL, MS, RR, sTNFR |
| 55 |
2017 |
Increased Levels of Oxidative Stress Markers, Soluble CD40 Ligand, and Carotid Intima-Media Thickness Reflect Acceleration of Atherosclerosis in Male Patients with Ankylosing Spondylitis in Active Phase and without the Classical Cardiovascular Risk Factors. |
AS, IMT, PAPP-A, PlGF |
| 56 |
2017 |
Is peritoneal dialysis causing a measurable burden of inflammatory and endothelial injury on top of metabolic syndrome? |
IL-6, MCP-1, MPO, MS, PD, sICAM-1, sTNFR |
| 57 |
2017 |
Markers of Subclinical Cardiovascular Disease in Nonfunctional Adrenal Incidentaloma Patients without Traditional Cardiovascular Risk Factors. |
AIx, CIMT, DST, NFAI, PWV |
| 58 |
2017 |
Metabolism-associated danger signal-induced immune response and reverse immune checkpoint-activated CD40+ monocyte differentiation. |
APC, MADS, RF, Tc |
| 59 |
2017 |
Non-survivor septic patients have persistently higher serum sCD40L levels than survivors. |
TNF |
| 60 |
2017 |
Replacement therapy with levothyroxine modulates platelet activation in recent-onset post-thyroidectomy subclinical hypothyroidism. |
8-iso-PGF2alpha |
| 61 |
2017 |
Soluble CD40 Ligand and Oxidative Response Are Reciprocally Stimulated during Shiga Toxin-Associated Hemolytic Uremic Syndrome. |
HGEC, HUS, ROS, Stx |
| 62 |
2017 |
Soluble CD40 ligand contributes to blood-brain barrier breakdown and central nervous system inflammation in multiple sclerosis and neuromyelitis optica spectrum disorder. |
BBB, CSF, DC, MS, NMOSD |
| 63 |
2017 |
Soluble CD40L is associated with increased oxidative burst and neutrophil extracellular trap release in Behcet's disease. |
BD, NET, PBMCs |
| 64 |
2017 |
Sphingosine 1-phosphate (S1P) suppresses the collagen-induced activation of human platelets via S1P4 receptor. |
HSP27, PDGF, S1P, S1PRs |
| 65 |
2017 |
The relationship between soluble CD40 ligand level and atherosclerosis in white-coat hypertension. |
CIMT, HT, WCH |
| 66 |
2016 |
A Pair of Identical Twins Discordant for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Differ in Physiological Parameters and Gut Microbiome Composition. |
ACTH, CK, CPET, LDH, ME/CFS, PEM, sFasL |
| 67 |
2016 |
Association of platelet activation markers with cancer-associated venous thromboembolism. |
CATS, OR, PF4, sP-selectin, TSP-1, VTE |
| 68 |
2016 |
Association of Soluble CD40 Ligand WithDuration of Atrial Fibrillation andWith Intensity of Spontaneous Echocardiographic Contrast. |
AUC, NVAF, SEC |
| 69 |
2016 |
Characterization of Innate Immunity in an Extended Whole Blood Model of Human Islet Allotransplantation. |
I-TAC, IBMIR, IP-10, MCP-1, MIG, TAT |
| 70 |
2016 |
Diagnostic utility of VEGF and soluble CD40L levels in serum of Alzheimer's patients. |
AD, CI, VEGF |
| 71 |
2016 |
Impact of Whole-Blood Processing Conditions on Plasma and Serum Concentrations of Cytokines. |
GM-CSF, IL, MIP-1alpha, ROC |
| 72 |
2016 |
Levels of human platelet-derived soluble CD40 ligand depend on haplotypes of CD40LG-CD40-ITGA2. |
--- |
| 73 |
2016 |
Magnitude and Quality of Cytokine and Chemokine Storm during Acute Infection Distinguish Nonprogressive and Progressive Simian Immunodeficiency Virus Infections of Nonhuman Primates. |
AUC, G-CSF, HIV, IL-15, MCP-1, MIP-1beta, NHP, SAA, SIV |
| 74 |
2016 |
Multiplex Immunoassay of Plasma Cytokine Levels in Men with Alcoholism and the Relationship to Psychiatric Assessments. |
ASS, BIS, G-CSF, GRO, IP-10, MCP-1, MDC, RANTES, SCL-90-R |
| 75 |
2016 |
Parathyroidectomy in asymptomatic primary hyperparathyroidism reduces carotid intima-media thickness and arterial stiffness. |
CIMT, PHPT, PWV |
| 76 |
2016 |
Platelet activation markers overexpressed specifically in patients with aspirin-exacerbated respiratory disease. |
AERD, ATA, sP-selectin |
| 77 |
2016 |
Platelet components associated with adverse reactions: predictive value of mitochondrial DNA relative to biological response modifiers. |
AEs, BRMs, mtDNA, PCs, PLTs |
| 78 |
2016 |
Platelet-specific markers are associated with monocyte-platelet aggregate formation and thrombin generation potential in advanced atherosclerosis. |
AUC, MPA, PF, sP-selectin, TSP |
| 79 |
2016 |
Predicting neurological deficit severity due to subarachnoid haemorrhage: soluble CD40 ligand and platelet-derived growth factor-BB. |
CRP, mRS, PDGF, SAH, WBC |
| 80 |
2016 |
Serum soluble CD40 ligand levels after acute intracerebral hemorrhage. |
ICH, NIHSS |
| 81 |
2016 |
Serum soluble CD40L concentration depending on the stage of multiple myeloma and its correlation with selected angiogenic cytokines. |
IL-6, MM, PDGF-AB, sIL-6R, sVCAM-1, TNF-alpha |
| 82 |
2016 |
Soluble CD40 ligand profiles in patients with septic shock. |
ICU, WBC |
| 83 |
2016 |
Stratification of ST-elevation myocardial infarction patients based on soluble CD40L longitudinal changes. |
AMI, NT-proBNP, PCI |
| 84 |
2016 |
The association between impaired glucose tolerance and soluble CD40 ligand: a 15-year prospective cohort study. |
IGT, non-IGT, OGTT |
| 85 |
2016 |
Thrombus Aspirated from Patients with ST-Elevation Myocardial Infarction: Association between 3-Nitrotyrosine and Inflammatory Markers - Insights from ARTERIA Study. |
3-NO2-Tyr, CRP, PCI, STEMI, VCAM-1 |
| 86 |
2015 |
A simultaneous electrochemical multianalyte immunoassay of high sensitivity C-reactive protein and soluble CD40 ligand based on reduced graphene oxide-tetraethylene pentamine that directly adsorb metal ions as labels. |
DPV, ELISA, hs-CRP, rGO-TEPA |
| 87 |
2015 |
Anti-citrullinated protein antibodies contribute to platelet activation in rheumatoid arthritis. |
ACPA, pos, RA |
| 88 |
2015 |
Assessment of mean platelet volume and soluble CD40 ligand levels in patients with non-dipper hypertension, dippers and normotensives. |
BP, DBP, DHT, MPV, NDHT, SBP |
| 89 |
2015 |
Changes of soluble CD40 ligand in the progression of acute myocardial infarction associate to endothelial nitric oxide synthase polymorphisms and vascular endothelial growth factor but not to platelet CD62P expression. |
AMI, eNOS, VEGF |
| 90 |
2015 |
Effect of pioglitazone combined with simvastatin on the CD40-CD40 ligand system in rabbits with atherosclerosis. |
CD40-CD40L, HDL-C, hs-CRP, LDL-C, MMP-9, sICAM-1, sVCAM-1, TC, TG |
| 91 |
2015 |
HIV-1 induces in vivo platelet activation by enhancing platelet NOX2 activity. |
cART, HS, sNOX2-dp |
| 92 |
2015 |
Increased plasma soluble CD40 ligand concentration in pelvic inflammatory disease. |
aOR, CRP, PID |
| 93 |
2015 |
Interruption of CD40 Pathway Improves Efficacy of Transplanted Endothelial Progenitor Cells in Monocrotaline Induced Pulmonary Arterial Hypertension. |
EPCs, Lv, MCT, PAH |
| 94 |
2015 |
Longitudinal assessment of immuno-metabolic parameters in multiple sclerosis patients during treatment with glatiramer acetate. |
GA, MCP-1, MPO, OPG, RRMS, sICAM-1, sLep-R, sTNFR |
| 95 |
2015 |
Men with lower HDL cholesterol levels have significant increment of soluble CD40 ligand and high-sensitivity CRP levels following the cessation of long-term clopidogrel therapy. |
HDL-C, hs-CRP, LDL-C |
| 96 |
2015 |
New Prognostic Biomarkers in Patients With Traumatic Brain Injury. |
CK, MDA, MMPs, NK1R, SP, TBI, TIMP, TNF |
| 97 |
2015 |
Platelet-derived microparticles induce polymorphonuclear leukocyte-mediated damage of human pulmonary microvascular endothelial cells. |
BRMs, HMVEC, ICAM-1, LPS, MoAb, PLTs, PMN, PMPs |
| 98 |
2015 |
Progression of matrixin and cardiokine expression patterns in an ovine model of heart failure and recovery. |
FGF, INF, LVEF, LVF, LVH, MMP, VEGF |
| 99 |
2015 |
Protective effects of tanshinone ⅡA on endothelial progenitor cells injured by tumor necrosis factor-alpha. |
EPCs |
| 100 |
2015 |
Reproducibility over time and effect of low-dose aspirin on soluble P-selectin and soluble CD40 ligand. |
CV, sPselectin |
|
A Search Service for Abbreviation / Long Form
